Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1139/cjm-2020-0421 http://scihub22266oqcxt.onion/10.1139/cjm-2020-0421 33136431!?!33136431       Can+J+Microbiol 2021 ; 67 (2): 112-118 Nephropedia Template TP {{tp|p=33136431|t=2021. COVID-19 basics and vaccine development with a Canadian perspective |pdf=|usr=}}{{33136431}} gab.com Text COVID-19 basics and vaccine development with a Canadian perspective JO: Can J Microbiol http://www.kidney.de/pget.php?&tw=1&pmid=33136431 #FOAvip The ongoing coronavirus disease 2019 (COVID-19) pandemic is a rapidly evolving situation. New discoveries about COVID-19 and its causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continue to deepen the understanding of this novel disease. As there is currently no COVID-19 specific treatment, isolation is the most effective method to prevent transmission. Moreover, development of a safe and effective COVID-19 vaccine will be instrumental in reinstating pre-COVID-19 conditions. As of 31 July 2020, there are at least 139 vaccine candidates from around the globe in preclinical evaluation, with another 26 undergoing clinical evaluation. This paper aims to review the basics of COVID-19, including epidemiology, basic biology of SARS-CoV-2, and transmission. We also review COVID-19 vaccine development, including animal models, platforms under development, and vaccine development in Canada. Twit Text FOAVip COVID-19 basics and vaccine development with a Canadian perspective ????Can J Microbiol http://www.kidney.de/pget.php?&tw=1&pmid=33136431 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33136431 #FOAvip English Wikipedia <ref>{{Cite pmid|33136431}}</ref> COVID-19 basics and vaccine development with a Canadian perspective #MMPMID33136431 Liu M; Chen X Can J Microbiol 2021[Feb]; 67 (2): 112-118 PMID33136431show ga The ongoing coronavirus disease 2019 (COVID-19) pandemic is a rapidly evolving situation. New discoveries about COVID-19 and its causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continue to deepen the understanding of this novel disease. As there is currently no COVID-19 specific treatment, isolation is the most effective method to prevent transmission. Moreover, development of a safe and effective COVID-19 vaccine will be instrumental in reinstating pre-COVID-19 conditions. As of 31 July 2020, there are at least 139 vaccine candidates from around the globe in preclinical evaluation, with another 26 undergoing clinical evaluation. This paper aims to review the basics of COVID-19, including epidemiology, basic biology of SARS-CoV-2, and transmission. We also review COVID-19 vaccine development, including animal models, platforms under development, and vaccine development in Canada. |*COVID-19 Vaccines[MESH] |*SARS-CoV-2/chemistry/genetics[MESH] |Animals[MESH] |COVID-19/epidemiology/*prevention & control[MESH] |Canada/epidemiology[MESH] |Cricetinae[MESH] |Ferrets[MESH] |Humans[MESH] |Mesocricetus[MESH] |Models, Animal[MESH]COVID-19 basics and vaccine development with a Canadian perspective (epmc).pdf DeepDyve Pubget Overpricing